Binod Shankar CFA Hit by the shock of the 2008 financial crisis and ongoing scandals around money laundering, rogue trading, rate manipulation,
Wealth management: Who do you trust?
Categories
Research Summary
Financial Analysis In Special Situations
Binod Shankar CFA Whether you are an owner, FP&A manager, banker, equity analyst, or an investor, what numbers and ratios should you
Alteryx (AYX) stock research summary
Value investors are constantly on the lookout for high-performance stocks at discounted rates. The lucrative SaaS industry has a lot on offer
Research Tear Sheet: Advanced Micro Devices (NASDAQ: AMD) stock
While the slowdown witnessed in the semiconductor industry late last year and the first half of this year seems to have finally
Research Tear Sheet: Village Farms International (VFF) stock
Last year, Canada became the breeding ground for numerous pot stocks following the country’s decision to legalize the use of marijuana for
What is NASH and which biotech firms are vying for the first-mover status
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards this liver disorder is
Luxembourg creates national ‘AI lab’ with NVIDIA
Luxembourg, one of the smallest countries in Europe, joined hands with microchip and graphics card giant Nvidia (NVDA) to launch a national
Robert Swan named Intel CEO after 7-month search
Putting an end to a seven-month-long search, Intel Corporation (INTC) has announced that Robert "Bob" Swan, who was serving as the interim-CEO
What to expect from General Electric Q4 earnings results
Many investors who picked up General Electric (GE) stock at dirt cheap prices are looking forward to the fourth quarter results, in
PG&E feels the heat of wildfires, files for bankruptcy protection
The devastating California wildfires have finally taken their toll on energy company PG&E (PGC), which is left with no other option but
Nvidia stock tumbles on reduced Q4 outlook
Nvidia Corp. (NVDA) tumbled about 15% in the pre-market trading hours today as the semiconductor giant cut down its revenue expectations for
China situation spurs more cuts as oil prices fall further
On Jan. 28, Monday, oil prices slipped following indications that crude production might rise further after US energy companies added rigs for
Advanced Micro Devices (AMD) is set to report positive earnings results for Q4
Advanced Micro Devices (AMD) is slated to release its fourth quarter and full-year 2018 results on Tuesday, January 29 after the bell.
Can Q1 earnings end Apple’s bad news streak?
If companies can experience nightmares, Apple (AAPL) just had one. The ever-so-formidable stock with a strong product portfolio and solid fundamentals had
Higher raw material costs likely to impact The 3M Company (MMM) Q4 earnings
The 3M Company (MMM) is scheduled to post its fourth-quarter 2018 earnings before trading hours on Tuesday, Jan. 29. The Street expects
Autonomous flying taxi nears reality after Boeing conducts test flight
For most people, autonomous flying taxi is yet another science fiction concept, even after the first successful tests were conducted more than
Former Tesco finance executive Carl Rogberg cleared of fraud in 2014 scandal
Tesco's former senior director Carl Rogberg on Wednesday was officially cleared of charges related to false accounting and fraud slapped on him
Google hit with $57-million fine by France, peers under radar
Google, a business unit of Alphabet Inc. (GOOGL), was handed a fine of $57 million by France’s data-privacy agency, CNIL, for violating
Eli Lilly’s oncology push suffers a blow after sarcoma drug fails study
The ambitious cancer therapy program of Eli Lilly and Company (LLY) suffered a setback Friday after a formulation developed by the drug
Nissan might sue ousted chairman Carlos Ghosn
Renault SA chief and former Nissan Motor Co chairman Carlos Ghosn might be facing a civil suit from the carmaker after his
Verona Pharma stock plunges to all time low on disappointing trial
Verona Pharma plc (VRNA) stock plunged to an all-time low of $5.76 on Monday as its lead chronic inflammatory lung disease treating